Candida species are the most common cause of nosocomial fungal infections and the fourth most common cause of hospital-acquired illnesses. Fungal infection has been known to cause severe complications and even death in immunocompromised patients. With the rise in antibiotic resistance and an increase in invasive medical procedures, ICU patients are becoming more vulnerable to this infection. In order to fight this epidemic, it is essential to comprehend the causes, signs, and available treatments for Candida species. Candida auris is an exceptionally rare type of fungus that first surfaced in 2009 and poses a threat to global health. C auris-associated invasive infections have a greater mortality rate than infections caused by other Candida species. C. auris possesses a tendency to develop antifungal medication resistance, which would make therapy more challenging. While the precise cause of C. auris illnesses is uncertain, it is believed that healthcare workers can contract the illness by touching infected objects or surfaces. Medical professionals, nurses, and various other staff members all contribute significantly to preventing the transmission of C. auris infestations. Utilizing hand hygiene techniques like thorough hand washing or hand sanitizers that contain alcohol can significantly reduce the spread of fungi. It is crucial to provide healthcare workers with ongoing instruction in infection control, the proper use of antifungal medications, and the early identification of C. auris infections.